iShares Biotechnology ETF $IBB Shares Purchased by Assetmark Inc.

Assetmark Inc. boosted its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 3.6% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 76,710 shares of the financial services provider’s stock after buying an additional 2,681 shares during the quarter. Assetmark Inc. owned approximately 0.16% of iShares Biotechnology ETF worth $12,952,000 as of its most recent filing with the SEC.

A number of other large investors have also recently bought and sold shares of IBB. Dynamic Wealth Strategies LLC raised its holdings in shares of iShares Biotechnology ETF by 16.6% in the fourth quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock worth $71,000 after acquiring an additional 60 shares during the last quarter. Flagship Private Wealth LLC boosted its stake in shares of iShares Biotechnology ETF by 2.0% during the fourth quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock valued at $521,000 after acquiring an additional 60 shares during the last quarter. Larson Financial Group LLC boosted its stake in shares of iShares Biotechnology ETF by 2.3% during the fourth quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock valued at $458,000 after acquiring an additional 60 shares during the last quarter. Webster Bank N. A. boosted its stake in shares of iShares Biotechnology ETF by 1.0% during the fourth quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock valued at $1,093,000 after acquiring an additional 62 shares during the last quarter. Finally, Choreo LLC increased its position in iShares Biotechnology ETF by 2.2% during the 4th quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock worth $514,000 after purchasing an additional 65 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB stock opened at $189.76 on Monday. The firm has a 50-day moving average price of $177.79 and a 200 day moving average price of $173.41. iShares Biotechnology ETF has a twelve month low of $128.84 and a twelve month high of $199.05.

iShares Biotechnology ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were issued a dividend of $0.0238 per share. The ex-dividend date was Monday, June 15th. This represents a $0.10 dividend on an annualized basis and a dividend yield of 0.1%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.